| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.009 | 0.8 |